Yildiz MALDI MS signature for lung cancer
A serum proteomic signature of seven features identified by MALDI MS has been identified. The serum signature was associated with the diagnosis of lung cancer independently of gender, smoking status, smoking pack-years, and C-reactive protein levels.
No member markers defined for this panel.
There are no datasets associated with this biomarker.